Single-agent INCB053914 upregulated PIM2 and inhibited phosphorylation of multiple substrates in hematologic cancer cell lines as well as in patient-derived primary AML cells. The gene discussed is PIM2; the disease is hematopoietic and lymphoid cell neoplasm.